Spyre Therapeutics, Inc.

BNP PARIBAS FINANCIAL MARKETS SYRE

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/9/2023

Value ($000)

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/9/2023	0	0.0%	1	6/30/2023
2023 Q1	5/12/2023	0	0.0%	396	3/31/2023
2022 Q4	2/14/2023	1	0.0%	2,968	12/31/2022
2022 Q3	11/16/2022	1	0.0%	1,575	9/30/2022
2022 Q2	8/12/2022	3	0.0%	5,269	6/30/2022
2022 Q1	5/18/2022	8	0.0%	3,580	3/31/2022
2021 Q4	2/9/2022	53	0.0%	11,159	12/31/2021
2021 Q3	11/16/2021	86	0.0%	10,756	9/30/2021
2021 Q2	8/10/2021	33	0.0%	4,705	6/30/2021
2021 Q1	5/7/2021	55	0.0%	6,960	3/31/2021
2020 Q4	2/10/2021	69	0.0%	8,810	12/31/2020
2020 Q3	10/30/2020	71	0.0%	9,945	9/30/2020
2020 Q2	8/6/2020	18	0.0%	1,933	6/30/2020
2020 Q1	5/13/2020	38	0.0%	8,073	3/31/2020
2019 Q4	2/12/2020	25	0.0%	3,224	12/31/2019